People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Ozempic (semaglutide) and Mounjaro (tirzepatide) are brand-name solutions for subcutaneous injection. Doctors prescribe them to help manage blood sugar levels in people with type 2 diabetes.

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

For Ozempic, the starting dose is 0.25 milligrams. After four weeks, this increases to 0.5 milligrams. After another four weeks, it can go up to 1 milligram and then up to 2 milligrams four weeks ...